Piramal Pharma Solutions began production of initial batches of active pharmaceutical ingredients (APIs) in new reactor suites at its facility in Riverview, MI. Project PRIME (Piramal Riverview Integrated Manufacturing Expansion) Phase 1, commenced in May of 2021. The initial production run is the culmination of a capital expenditure of $38 million in equipment and construction costs at Piramal’s API site in Aurora, Ontario, Canada. The facility covers approximately 25,000 square feet of s...